Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Assets Average (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Assets Average data on record, last reported at $44.0 million in Q4 2025.

  • For Q4 2025, Assets Average rose 1.11% year-over-year to $44.0 million; the TTM value through Dec 2025 reached $44.0 million, up 1.11%, while the annual FY2025 figure was $50.6 million, 25.39% down from the prior year.
  • Assets Average reached $44.0 million in Q4 2025 per VRCA's latest filing, up from $40.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $103.6 million in Q2 2021 and bottomed at $40.0 million in Q3 2025.
  • Average Assets Average over 5 years is $63.8 million, with a median of $59.2 million recorded in 2024.
  • Peak YoY movement for Assets Average: surged 90.42% in 2023, then tumbled 51.29% in 2024.
  • A 5-year view of Assets Average shows it stood at $84.4 million in 2021, then crashed by 44.42% to $46.9 million in 2022, then soared by 90.42% to $89.4 million in 2023, then crashed by 51.29% to $43.5 million in 2024, then grew by 1.11% to $44.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $44.0 million in Q4 2025, $40.0 million in Q3 2025, and $40.6 million in Q2 2025.